Generated by AI
Anbio Biotechnology Ltd is a medical device company focused on in vitro diagnostics. Anbio Biotechnology develops and supplies diagnostic products for over-the-counter use, point-of-care testing, and laboratory applications, serving healthcare providers and patients in multiple settings. Its portfolio spans several testing technologies, including fluorescence immunoassay, chemiluminescence immunoassay, lateral flow immunoassay, loop-mediated isothermal amplification, dry chemistry, and real-time polymerase chain reaction. The company also offers rapid antigen test kits for respiratory infections and other diagnostic needs. With a global presence across major international markets, Anbio Biotechnology plays a role in expanding access to fast, decentralized diagnostic tools used in infectious disease detection and broader biomarker testing.
WebsiteFriedrich-Ebert-Anlage 35-37
Frankfurt am Main, 60327
Germany
The latest articles about NNNN.
Summary of Aug 17's posts. Generated by AI.
No summary yet.
Summary of Feb 2's posts. Generated by AI.
No summary yet.
Summary of Feb 2's posts. Generated by AI.
Investors talking about NNNN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.